<DOC>
	<DOCNO>NCT00666822</DOCNO>
	<brief_summary>RATIONALE : Understanding well patient comply treatment regimen may help doctor plan best treatment ongoing care . PURPOSE : This clinical trial study whether patient comply hormone therapy regimen woman estrogen receptor-positive stage I , stage II , stage IIIA breast cancer .</brief_summary>
	<brief_title>Compliance Hormone Therapy Regimen Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To examine relationship adherence endocrine therapy variables Health Belief Model ( i.e. , perceive risk , barrier benefit adherence , cue action physician recommendation ) well measure patient 's perception patient- family-centered care woman estrogen receptor-positive stage I-IIIA breast cancer . OUTLINE : Patients complete 15 minute questionnaire on-line mail comprise question demographic medical variable ( i.e. , age , race/ethnicity , marital educational status , medication side effect ) well health belief select aspect patient- family-centered care . Data collect questionnaire store Excel database . Patient 's medical record review information time since diagnosis , tumor characteristic , treatment , comorbidity .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Women diagnose breast cancer Stage IIIIA disease Estrogen receptor ( ER ) positive disease Must begin prescribed hormonal therapy December 2000 December 2002 No prior history breast cancer PATIENT CHARACTERISTICS : Female Menopausal status specify Able read understand English PRIOR CONCURRENT THERAPY : See Disease Characteristics Prior breast surgery , axillary surgery , radiotherapy breast chest wall allow</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>